Lenalidomide and Rituximab Regimen Combined With Intravitreal Methotrexate Followed by Lenalidomide Maintenance for Primary Vitreoretinal Lymphoma: A Prospective Phase II Study

Lenalidomide and Rituximab Regimen Combined With Intravitreal Methotrexate Followed by Lenalidomide Maintenance for Primary Vitreoretinal Lymphoma: A Prospective Phase II Study

Primary vitreoretinal lymphoma (PVRL) is a rare variant of primary central nervous system (CNS) lymphoma, for which currently there are no optimal treatment options. This prospective single-center study enrolled immunocompetent patients with newly diagnosed PVRL between August 2018 and January 2020....

Full description

Bibliographic Details
Main Authors: Yan Zhang, Xiao Zhang, Dongmei Zou, Jingjing Yin, Li Zhang, Xuan Wang, Congwei Jia, Wei Wang, Danqing Zhao, Daobin Zhou, Wei Zhang, Meifen Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
primary vitreoretinal lymphoma (PVRL)
rituximab
lenalidomide
intravitreal methotrexate injection
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.701507/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.701507/full

Similar Items